Research Papers
This database includes peer-reviewed publications authored or funded by TB Alliance. Use the tags on the right to filter by subject, or search for a particular author or term using the search bar.
Displaying 190 papers
No antimicrobial resistance research agenda without tuberculosis
8/2020 - The Lancet Global Health
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
3/2020 - The New England Journal of Medicine
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
1/2020 - Antimicrobial Agents and Chemotherapy
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial
11/2019 - The Lancet Respiratory Medicine
Daily Dosing for Bedaquiline in Patients with Tuberculosis
10/2019 - Antimicrobial Agents and Chemotheraphy
Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations
9/2019 - BMC Infectious Diseases
Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
8/2019 - BMC Pulmonary Medicine
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
8/2019 - Antimicrobial Agents and Chemotheraphy
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
7/2019 - Antimicrobial Agents and Chemotheraphy
Antibacterial Activity of Coastal Plants and Marine Sponges from Kei Island Indonesia against Bacterial Fish Pathogens
7/2019 - Pharmacognosy Journal
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
4/2019 - Antimicrobial Agents and Chemotheraphy
An Assessment of Global Chemistry, Manufacturing and Controls (CMC) Regulatory Requirements in Low and Middle Income Countries
11/2018 - WHO Drugs Journal
Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMox TB study
10/2018 - BMC Medicine (2018) 16:189
Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
7/2018 - BMC Infectious Diseases
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis.
5/2018 - BMC Medicine
Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study
3/2018 - BMC Medicine
Antitubercular nitroimidazoles revisited: synthesis and activity of the authentic 3-nitro isomer of pretomanid
12/2017 - ACS Medicinal Chemistry Letters
Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis
12/2017 - BMC Medicine 2017 15:207
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimens
12/2017 - BMC Medicine 2017 15:207